DCE-MRI biomarkers of tumor cytoablation efficacy and subsequent recurrence in an orthotopic, preclinical glioblastoma model

Authors

Tavarekere N. Nagaraja, Henry Ford HealthFollow
Seamus Bartlett, Henry Ford HealthFollow
Glauber Cabral, Henry Ford HealthFollow
Katelynn G. Farmer, Henry Ford HealthFollow
F. Avritt
Prabhu Acharya, Henry Ford HealthFollow
Olivia Valadie, Henry Ford HealthFollow
Robert A. Knight, Henry Ford HealthFollow
Stephen L. Brown, Henry Ford HealthFollow
James R. Ewing, Henry Ford HealthFollow
Ian Lee, Henry Ford HealthFollow

Recommended Citation

Nagaraja T, Bartlett S, Cabral G, Farmer K, Avritt F, Acharya P, Valadie O, Knight R, Brown S, Ewing J, and Lee I. DCE-MRI biomarkers of tumor cytoablation efficacy and subsequent recurrence in an orthotopic, preclinical glioblastoma model. J Cereb Blood Flow Metab 2022; 42(1_SUPPL):187-187.

Document Type

Conference Proceeding

Publication Date

6-1-2022

Publication Title

J Cereb Blood Flow Metab

Volume

42

Issue

1 Suppl

First Page

187